Thomas Pfisterer is of ADC Therapeutics SA. Currently has a direct ownership of 173,899 shares of ADCT, which is worth approximately $469,527. The most recent transaction as insider was on May 15, 2025, when has been sold 451,856 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 174K
18.7% 3M change
18.7% 12M change
Total Value Held $469,527

Thomas Pfisterer Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2025
SELL
Other acquisition or disposition
-
451,856 Reduced 72.21%
173,899 Common Shares
Jun 17 2024
SELL
Open market or private sale
$4,152 $2.89 p/Share
1,437 Reduced 0.67%
213,900 Common Shares
Jun 13 2024
BUY
Grant, award, or other acquisition
-
40,000 Added 15.67%
215,337 Common Shares
TP

Thomas Pfisterer

New Providence, NJ

Track Institutional and Insider Activities on ADCT

Follow ADC Therapeutics SA and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADCT shares.

Notify only if

Insider Trading

Get notified when an Adc Therapeutics Sa insider buys or sells ADCT shares.

Notify only if

News

Receive news related to ADC Therapeutics SA

Track Activities on ADCT